Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Best Practices for COVID-19 Regulatory Waivers, Relief Funding & Audits

Steven M. Harris, Esq.  |  Issue: September 2020  |  September 11, 2020

Telemedicine & Telehealth Services

The COVID-19 pandemic has vastly accelerated the use of telehealth. This particular area of healthcare is extraordinarily ripe for audit activity due to the sharp increase in its use and the potential for error in coding and billing applied to the wide range of new services and waivers, and also for differences in government and commercial payer coverage and reimbursement. The primary changes in public health emergency telemedicine include:

  • State and CMS waivers that permit interstate practice and additional types of authorized providers;
  • HIPAA enforcement discretion for use of certain non-public-facing audio or video communication products;
  • DEA waiver of in-person evaluation for remote prescribing of certain controlled substances;
  • OIG flexibility for providers to reduce or waive beneficiary cost sharing;
  • CMS flexibilities allowing both provider and patient remote or at-home service locations;
  • CMS flexibility to allow audio-only services;
  • CMS waivers extending many services to new patients; and
  • CMS waivers increasing reimbursement for virtual patient visits.

Providers should anticipate rigorous review of telemedicine services at the state and federal levels. The OIG noted in June and July that it intends to review Medicare and Medicaid telehealth activity and reimbursement during the COVID-19 public health emergency. The OIG is not alone in its interest in suspected telehealth fraud and abuse. The CMS and other federal and state agencies will likely engage in audits.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Best practices: Providers who used or increased telemedicine and telehealth services during the public health emergency should consider conducting internal and external compliance checks for specific billing and coding practices; developing or enhancing compliance programs and policies for continued virtual service documentation; and requiring training or updated policy review for clinicians and coding staff prior to the submission of future claims.  


Steven M. Harris, Esq.Steven M. Harris, Esq., is a nationally recognized healthcare attorney with McDonald Hopkins LLC. Contact him at [email protected].

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:Billing/CodingLegal Updates Tagged with:CARES ActCenters for Medicare & Medicaid Services (CMS)COVID-19telemedicineU.S. Department of Health and Human Services (HHS)

Related Articles

    Design a Compliance Plan for Your Rheumatology Practice

    March 1, 2015

    Tips for creating, maintaining and enforcing an effective plan

    Reporting & Other Tips for the CARES Act Provider Relief Fund

    February 16, 2021

    Between April and December 2020, many eligible healthcare providers received or applied for payments from the $175 billion Coronavirus Aid, Relief and Economic Security (CARES) Act Provider Relief Fund (PRF) through the U.S. Department of Health & Human Services (HHS). On Dec.27, 2020, the Consolidated Appropriations Act, 2021 (the Appropriations Act) was signed into law,…

    Rheumatology in a COVID & Post-COVID World

    May 11, 2020

    Jane’s* hands and wrists had been swollen and painful for about eight weeks. Lab findings in the ambulatory consult that came to our office revealed a cyclic citrullinated peptide antibody count >250 u/mL. We all know where this story goes, including how important the early treatment window is. Our clinic reviews all consults and tries…

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences